Clinical Research
Taiwan Lubricate for academic research and health products development
In the collaboration with Lipotype GmbH, Germany (the world leader in lipidomics profiling service), T-BAL has developed advanced multi-omics (ma...
November 20, 2023 | News
ACROBiosystems Introduces GM-Grade DLL4 Protein for Faster Stem Cell Manufacturing
The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...
November 17, 2023 | News
Groundbreaking milestone as the United Kingdom MHRA greenlights CASGEVY™, heralding a new era in CRISPR-based gene editing therapies
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...
November 17, 2023 | News
Kite Expands Collaboration with Arcellx, Exercises Option for ACLX-001 in Multiple Myeloma
-- The companies expand the scope of their existing collaboration for CART-ddBCMA to include lymphomas -- -- Kite exercises option to Arcellx’s ARC-...
November 16, 2023 | News
SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023
Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...
November 14, 2023 | News
Cromatic closes $5.3 million in oversubscribed seed round to modernize life science R&D outsourcing
Cromatic, a full-stack digital platform for outsourced life sciences research, announced it has closed $5.3 million in funding. LifeX Ventures ...
November 10, 2023 | News
Tempus Collaborates with Bristol Myers Squibb on Multimodal AI Research
"We are looking forward to expanding our relationship with Bristol Myers Squibb and furthering our shared commitment to advancing cancer research and treat...
November 09, 2023 | News
Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors
BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China Biotheus Inc. ("Biotheus"),...
November 07, 2023 | News
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...
November 03, 2023 | News
Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction
Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading bioph...
November 02, 2023 | News
YS Biopharma Completes Pivotal Phase 3 Enrollment for PIKA Rabies Vaccine Trial
Rabies has an almost 100% fatality rate upon emergence of clinical symptoms. Each year, it claims the lives of approximately 59,000 individuals in ...
November 01, 2023 | News
Rational Vaccines and Shenzhen Mellow Hope Partner on Herpes Vaccines in China
Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreement to jointly develop, manufacture, ...
October 31, 2023 | News
Clario's Opal® Technology Drives Breakthrough in Parkinson's Disease at University of Oxford
Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...
October 30, 2023 | News
Henlius Expands Partnership with Intas to Introduce Serplulimab in Europe and India
Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalt...
October 30, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
